Historial de carrera de Marlies Sproll
Antiguos cargos conocidos de Marlies Sproll.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| MORPHOSYS AG | Director Técnico/Científico/I+D | 19/05/2010 | 15/04/2017 |
Lanthio Pharma BV
 Lanthio Pharma BV Medical SpecialtiesHealth Technology Lanthio Pharma BV focuses on discovering and developing lantipeptides for the generation of novel peptide therapeutics. Its product is a lanthionine-stabilized specific agonist of the AT2 receptor, which has great potential in diseases where tissue protection is important, like fibrosis. The company was founded in 2010 and is headquartered in Groningen, the Netherlands. | Director/Miembro de la Junta | - | - |
Formación de Marlies Sproll.
| Max Planck Institute for Metals Research | Doctorate Degree |
Estadísticas
Internacional
| Alemania | 3 |
| Países Bajos | 2 |
Operativa
| Chief Tech/Sci/R&D Officer | 1 |
| Doctorate Degree | 1 |
| Director/Board Member | 1 |
Sectorial
| Health Technology | 3 |
| Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| MORPHOSYS AG | Health Technology |
| Empresas privadas | 1 |
|---|---|
Lanthio Pharma BV
Lanthio Pharma BV Medical SpecialtiesHealth Technology Lanthio Pharma BV focuses on discovering and developing lantipeptides for the generation of novel peptide therapeutics. Its product is a lanthionine-stabilized specific agonist of the AT2 receptor, which has great potential in diseases where tissue protection is important, like fibrosis. The company was founded in 2010 and is headquartered in Groningen, the Netherlands. | Health Technology |
- Bolsa de valores
- Insiders
- Marlies Sproll
- Experiencia